Patient and public preferences for being recontacted with updated genomic results: a mixed methods study
Authors:
- 18 September 2021
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 140 (12) , 1695-1708
Abstract
Variants of uncertain significance (VUS) are frequently reclassified but recontacting patients with updated results poses significant resource challenges. We aimed to characterize public and patient preferences for being recontacted with updated results. A discrete choice experiment (DCE) was administered to representative samples of the Canadian public and cancer patients. DCE attributes were uncertainty, cost, recontact modality, choice of results, and actionability. DCE data were analyzed using a mixed logit model and by calculating willingness to pay (WTP) for types of recontact. Qualitative interviews exploring recontact preferences were analyzed thematically. DCE response rate was 60% (n = 1003, 50% cancer patient participants). 31 participants were interviewed (11 cancer patients). Interviews revealed that participants expected to be recontacted. Quantitatively, preferences for how to be recontacted varied based on certainty of results. For certain results, WTP was highest for being recontacted by a doctor with updates ($1075, 95% CI: $845, $1305) and for contacting a doctor to request updates ($1038, 95% CI: $820, $1256). For VUS results, WTP was highest for an online database ($1735, 95% CI: $1224, $2247) and for contacting a doctor ($1705, 95% CI: $1102, $2307). Qualitative data revealed that preferences for provider-mediated recontact were influenced by trust in healthcare providers. Preferences for a database were influenced by lack of trust in providers and desire for control. Patients and public participants support an online database (e.g. patient portal) to recontact for VUS, improving feasibility, and provider-mediated recontact for certain results, consistent with usual care.Keywords
Funding Information
- Canadian Centre for Applied Research in Cancer Control (2015-703549)
- Canadian Institutes of Health Research (333703)
This publication has 54 references indexed in Scilit:
- Decision-Makers’ Preferences for Approving New Medicines in Wales: A Discrete-Choice Experiment with Assessment of External ValidityPharmacoEconomics, 2013
- Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task ForceValue in Health, 2013
- Non-trading, lexicographic and inconsistent behaviour in stated choice dataTransportation Research Part D: Transport and Environment, 2010
- Public participation in health care priority setting: A scoping reviewHealth Policy, 2009
- Identification of parameters in normal error component logit‐mixture (NECLM) modelsJournal of Applied Econometrics, 2007
- A comparison of approaches to estimating confidence intervals for willingness to pay measuresHealth Economics, 2007
- What influences participation in genetic carrier testing?Journal of Health Economics, 2006
- Using Stated Preference Modeling to Forecast the Effect of Medication Attributes on Prescriptions of Alcoholism MedicationsValue in Health, 2003
- Measuring Preferences for Health Care Interventions Using Conjoint Analysis: An Application to HIV TestingHealth Services Research, 2002
- Whatever happened to qualitative description?Research in Nursing & Health, 2000